home / stock / itci / itci articles

ITCI Articles, Intra-Cellular Therapies Inc. - From 04/16/24

Stock Information
Company Name: Intra-Cellular Therapies Inc.
Stock Symbol: ITCI
Market: NASDAQ
Website: intracellulartherapies.com
Menu
ITCI ITCI Quote ITCI Short ITCI News ITCI Articles ITCI Message Board
Get ITCI Alerts

News, Short Squeeze, Breakout and More Instantly...
Intra-Cellular Stock Rallies On Successful Late-Stage Depression Treatment Study | Benzinga

Intra-Cellular Therapies Inc (NASDAQ:ITCI) unveiled on Tuesday topline results from Study 501 evaluating lumateperone 42 mg as an adjunctive thera...
UnitedHealth Reports Upbeat Earnings, Joins Cullinan Oncology, Ericsson And Other Big Stocks Moving Higher On Tuesday | Benzinga

U.S. stocks were mostly higher, with the Dow Jones index gaining over 100 points on Tuesday. Shares of UnitedHealth Group Incorporated (NYSE: UNH)...

Intra-Cellular Therapies Announces Executive Appointments and Leadership Changes | Benzinga

NEW YORK, March 19, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), a biopharmaceutical company focused on the developmen...

Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences | Benzinga

NEW YORK, March 06, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), a biopharmaceutical company focused on the developmen...
Intra-Cellular Therapies to Present at the 44th Annual TD Cowen Health Care Conference | Benzinga

NEW YORK, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), a biopharmaceutical company focused on the development...

Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast | Benzinga

NEW YORK, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), a biopharmaceutical company focused on the developmen...

Intra-Cellular Therapies to Present at the 42nd Annual J.P. Morgan Healthcare Conference | Benzinga

NEW YORK, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), a biopharmaceutical company focused on the development...
Intra-Cellular Therapies Highlights Data Presentations at the American College of Neuropsychopharmacology Annual Meeting | Benzinga

Company presents positive results of a pre-specified patient population in Study 403 examining the effects of CAPLYTA® (lumateperone) in pati...

Intra-Cellular Therapies to Present at the 6th Annual Evercore ISI HealthCONx Conference | Benzinga

NEW YORK, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), a biopharmaceutical company focused on the development...

Intra-Cellular Therapies to Participate in Two Upcoming Investor Conferences | Benzinga

NEW YORK, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), a biopharmaceutical company focused on the development...
Previous 10 Next 10